This company is set to start final-stage trial of its coronavirus vaccine
The US-based pharmaceutical company Moderna on Thursday stated that it is set to begin the final-stage clinical trial of its vaccine candidate against the novel coronavirus by July. Moderna was the first company that started human clinical trials of its vaccine candidate in the US. The last stage of its study will include 30,000 people. It will be conducted in partnership with the US National Institute of Allergy and Infectious Diseases (NIAID).
The study will find out proof that Moderna’s vaccine actually prevents people from developing COVID-19. It will also find that it prevents at least severe symptoms and cases that require hospitalization. The second-stage clinical trial of Moderna took place last month. The company had stated that it has shown encouraging early results on a small group of healthy volunteers.
Moderna’s vaccine candidate is an mRNA vaccine, a technology that provides instructions to healthy cells to produce antibodies to the coronavirus.
